A Phase I/1b Study of Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Phase of Trial: Phase I
Latest Information Update: 30 May 2017
At a glance
- Drugs Enzalutamide (Primary)
- Indications Bladder cancer; Urethral cancer; Urogenital cancer
- Focus Adverse reactions
- 23 May 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 23 May 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 18 Feb 2017 Results (n=6) presented at the 2017 Genitourinary Cancers Symposium